Back to News
Market Impact: 0.55

LyondellBasell Announces Quarterly Dividend Increase to $1.37 Per Share

LYBBLKGSUBSWFCDBNDAQ
Corporate EarningsCapital Returns (Dividends / Buybacks)Company FundamentalsAnalyst InsightsInsider TransactionsAnalyst Estimates
LyondellBasell Announces Quarterly Dividend Increase to $1.37 Per Share

LyondellBasell (LYB) announced a $0.03 increase in its quarterly dividend to $1.37 per share, payable June 9, 2025, marking the 15th consecutive year of dividend growth. CEO Peter Vanacker cited the dividend growth as a sign of confidence in the company's capital strategy amid economic challenges. Recent institutional activity shows mixed sentiment, with Norges Bank and FMR LLC reducing their positions while BlackRock and Pacer Advisors increased theirs.

Analysis

LyondellBasell (LYB) has announced a $0.03 per share increase in its quarterly dividend to $1.37, payable on June 9, 2025, to shareholders of record as of June 2, 2025. This development marks the company's 15th consecutive year of dividend growth, a point emphasized by CEO Peter Vanacker as a reflection of confidence in LyondellBasell's disciplined capital deployment and resilience amidst economic challenges. Supporting this positive signal, insider trading activity over the past six months shows exclusively purchases, totaling 3 transactions, including Michael Sean Hanley acquiring 7,250 shares for approximately $469,731 and Robin W.T. Buchanan purchasing 5,000 shares for around $380,300. However, institutional sentiment appears mixed based on recent quarterly filings; Norges Bank reduced its holding by 3,285,688 shares (-75.1%) in Q4 2024, and FMR LLC divested 2,398,125 shares (-66.6%) in Q1 2025. Conversely, BlackRock increased its position by 2,798,219 shares (+11.4%) and Pacer Advisors significantly boosted its stake by 1,959,576 shares (+3502.2%) in Q1 2025. Analyst ratings are also varied, with three recent buy ratings (Fermium Research, Wells Fargo, RBC Capital) and one sell rating (UBS). The median price target from five analysts over the last six months stands at $70.0, with individual targets ranging from $51.0 (UBS) to $85.0 (Wells Fargo), indicating diverse market expectations for the chemical giant.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.